Literature DB >> 18685899

Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience.

Lia Assumpcao1, John L Cameron, Christopher L Wolfgang, Barish Edil, Michael A Choti, Joseph M Herman, Jean-Francois Geschwind, Kelvin Hong, Christos Georgiades, Richard D Schulick, Timothy M Pawlik.   

Abstract

BACKGROUND: No data on incidence, management, or natural history of chyle leaks following pancreatic resection have been published. We sought to identify possible risk factors associated with chyle leaks following pancreatic resection, as well as determine the natural history of this rare complication.
METHODS: Between 1993 and 2008, 3,532 patients underwent pancreatic resection at a single institution. Data on demographics, operative details, primary tumor status, and chyle leak were collected. To identify risk factors associated with chyle leak, a matched 3:1 paired analysis was performed.
RESULTS: Of 3,532 patients undergoing pancreatic resection, 47 (1.3%) developed a chyle leak (n = 34, contained chyle leak versus n = 13, diffuse chylous ascites). Chyle leak was identified at median 5 days following surgery. Median drain triglyceride levels were 592 ng/dl. After matching on tumor size, disease etiology, and resection type, the number of lymph nodes harvested and history of concomitant vascular resection predicted higher risk of chyle leak (both P < 0.05). Total parenteral nutrition (TPN) was required in more patients with chylous ascites (92.3%) than those with chyle leaks (44.1%) (P = 0.003). The median time to resolution was shorter for contained chyle leaks (13 days) versus chylous ascites (36 days) (P < 0.001). Patients with chylous ascites tended to have shorter overall survival (3-year, 18.8%) versus patients with no chyle leak (3-year, 46.9%) (P = 0.12). In contrast, patients with a contained chyle leak had a similar survival as patients with no chyle leak (3-year, 53.4% versus 46.9%, respectively) (P = 0.32).
CONCLUSION: Chyle leak was a rare (1.3%) complication following pancreatic resection that was associated with number of lymph nodes harvested and concomitant vascular resection. In general, chyle leaks were successfully managed with TPN with no adverse impact on outcome. Patients with chylous ascites, however, had a more protracted clinical course and tended to have a worse long-term survival.

Entities:  

Mesh:

Year:  2008        PMID: 18685899     DOI: 10.1007/s11605-008-0619-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  43 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

2.  Chylous leakage after circumferential thoracolumbar fusion for correction of kyphosis resulting from fracture. Report of three cases.

Authors:  H Nagai; K Shimizu; J Shikata; H Iida; M Matsushita; K Ido; T Nakamura
Journal:  Spine (Phila Pa 1976)       Date:  1997-12-01       Impact factor: 3.468

3.  The surgical significance of chylous ascites.

Authors:  J S Vasko; R I Tapper
Journal:  Arch Surg       Date:  1967-09

Review 4.  Postoperative chylous ascites: diagnosis and treatment. A series report and literature review.

Authors:  C J Ablan; F N Littooy; R J Freeark
Journal:  Arch Surg       Date:  1990-02

5.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

Review 6.  Combined occurrence of chyloperitoneum and chylothorax after surgery and chemotherapy for Wilms' tumor.

Authors:  S Jayabose; S Kogan; S Berezin; M Slim; J A San Filippo; L Godine; D Beneck; O Tugal; S Sunkara
Journal:  Cancer       Date:  1989-11-01       Impact factor: 6.860

7.  A rare complication of D3 dissection for gastric carcinoma: chyloperitoneum.

Authors:  Sinan Yol; Erdal Birol Bostanci; Yusuf Ozogul; Murat Ulas; Musa Akoglu
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

8.  Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis.

Authors:  M C Gallagher; A Shankar; C J Groves; R C G Russell; R K S Phillips
Journal:  Br J Surg       Date:  2004-09       Impact factor: 6.939

9.  Chylous ascites and lymphocyst management by peritoneovenous shunt.

Authors:  Y N Silk; W M Goumas; H O Douglass; R P Huben
Journal:  Surgery       Date:  1991-09       Impact factor: 3.982

10.  Evaluation and management of chylous ascites.

Authors:  O W Press; N O Press; S D Kaufman
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

View more
  36 in total

1.  Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system.

Authors:  Mi Ran Jung; Young Kyu Park; Jang Won Seon; Kwang Yong Kim; Oh Cheong; Seong Yeob Ryu
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

2.  Lymphangiography as a treatment method for chylous ascites following pancreaticoduodenectomy.

Authors:  Mathieu D'Hondt; Kristien Foubert; Freddy Penninckx; Raymond Aerts
Journal:  J Gastrointest Cancer       Date:  2011-12

Review 3.  Nutritional management in patients with chyle leakage: a systematic review.

Authors:  B R Steven; S Carey
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

4.  Small-volume chylous ascites after laparoscopic radical gastrectomy for gastric cancer: results from a large population-based sample.

Authors:  Jun Lu; Zhen-Quan Wei; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

5.  Surgical outcomes according to the type of monopolar electrocautery device used in laparoscopic surgery for right colon cancer: a comparison of endo-hook versus endo-shears.

Authors:  Jeehye Lee; Jung Rae Cho; Min Hyun Kim; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang
Journal:  Surg Endosc       Date:  2019-05-30       Impact factor: 4.584

6.  Drainage volume after pancreaticoduodenectomy is a warning sign of chyle leakage that inversely correlates with a diagnosis of pancreatic fistula.

Authors:  Jae Keun Kim; Joon Seong Park; Ho Kyoung Hwang; Hyun Wook Shin; Dong Sup Yoon
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

7.  Changes over time in milk test results following pancreatectomy.

Authors:  Hideki Aoki; Masashi Utsumi; Kenta Sui; Nobuhiko Kanaya; Tomoyoshi Kunitomo; Hitoshi Takeuchi; Norihisa Takakura; Shigehiro Shiozaki; Hiroyoshi Matsukawa
Journal:  World J Gastrointest Surg       Date:  2016-03-27

8.  Effect of High Postoperative Body Temperature on Long-Term Prognosis in Patients with Gastric Cancer After Radical Resection.

Authors:  Hua-Long Zheng; Jun Lu; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chao-Hui Zheng; Chang-Ming Huang
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

9.  Daily Triglyceride Output Volume as an Early Predictor for Chyle Leak Following Pancreaticoduodenectomy.

Authors:  Taro Sakamoto; Norimitsu Okui; Fumitake Suzuki; Ryoga Hamura; Yoshihiro Shirai; Koichiro Haruki; Kenei Furukawa; Toru Ikegami
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  Complications and failure to rescue following laparoscopic or open gastrectomy for gastric cancer: a propensity-matched analysis.

Authors:  Ru-Hong Tu; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Chang-Ming Huang
Journal:  Surg Endosc       Date:  2016-09-12       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.